IOVANCE BIOTHERAPEUTICS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Carlos, CA
SEC filing record 1 source field available
Fiscal year end
31 December
IOVANCE BIOTHERAPEUTICS, INC. has filed 1,011 SEC EDGAR filings since 29 Jan 2008

SEC filing history

Showing 901-925 of 984 matching filings.

Per page
25
Current page
37
8-K File 000-53127

FORM 8-K

Filing date
09 Jan 2012
Reporting date
09 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-53127

CURRENT REPORT

Filing date
22 Dec 2011
Reporting date
30 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
20 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 000-53127

CT ORDER filing

Filing date
19 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-175184

EFFECT filing

Filing date
16 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-53127

FORM 8-K/A

Filing date
13 Dec 2011
Reporting date
05 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
05 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-175184

AMENDMENT TO FORM S-3

Filing date
05 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53127

FORM 8-K

Filing date
05 Dec 2011
Reporting date
30 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-53127

AMENDMENT TO CURRENT REPORT

Filing date
29 Nov 2011
Reporting date
05 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
NT 10-Q File 000-53127

NT 10-Q

Filing date
15 Nov 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
10 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
27 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3/A File 333-175184

S-3/A

Filing date
27 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-85384

NONE

Filing date
21 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53127

FORM 8-K

Filing date
20 Oct 2011
Reporting date
03 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 000-53127

AMENDMENT TO FORM 8-K

Filing date
13 Oct 2011
Reporting date
05 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-53127

FORM 8-K

Filing date
11 Oct 2011
Reporting date
05 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
30 Sep 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
30 Sep 2011
Reporting date
22 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
30 Sep 2011
Reporting date
13 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Sep 2011
Reporting date
21 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
26 Sep 2011
Reporting date
20 Jul 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .